• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Edwards Lifesciences

Edwards Lifesciences

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Global Clot Management Devices Market (2016-2022) - By Product, End User & Region - Research and Markets

    Global Clot Management Devices Market (2016-2022) - By Product, End User & Region - Research and Markets

  2. Global Transcatheter Mitral Valve Replacement (TMVR) Market Report 2017: Industry Analysis, Size, Share, Trends and Forecast, 2014-2022 - Research and Markets

    Global Transcatheter Mitral Valve Replacement (TMVR) Market Report 2017: Industry Analysis, Size, Share, Trends and Forecast, 2014-2022 - Research and Markets

  3. UPDATE: Trump's 'Obamacare Lite' presents opportunities and perils for investors

    UPDATE: Trump's 'Obamacare Lite' presents opportunities and perils for investors

  4. Which Funds Own My Stock?

    Ownership data provide a look at who else owns the company.

  5. No Surprises in Medtronic's Fiscal Third Quarter

    The firm is on track to meet our full-year estimates, and our $60 per share fair value estimate and wide moat rating are intact.

  6. A Contrarian Bent

    Disciplined Growth Investors’ managers have built a moderate allocation strategy unlike most others.

  7. 2014's Biggest Stock Winners: Is There Any Gas Left in the Tank?

    Declining fuel prices stoked great returns at several of these companies, but that's not a lasting advantage.

  8. Home Prices Keep Falling

    The information and opinions presented herein are not meant to be taken as investment advice. We do our best to make sure the information presented in this article is factual and correct, but Zacks cannot be held responsible for any losses incurred from investment transactions made based on ...

©2017 Morningstar Advisor. All right reserved.